Ralph Charlton
Chief Tech/Sci/R&D Officer at SPRUCE BIOSCIENCES, INC.
Net worth: 28 683 $ as of 2024-06-29
Profile
Ralph William Charlton is currently the Chief Medical Officer at Spruce Biosciences, Inc. Prior to this, he worked as the Executive Medical Director at Allergan, Inc. from 2018 to 2019, Senior Medical Director-Clinical Development at Ascendis Pharma, Inc. from 2019 to 2020, and Vice President-Clinical Development at 89bio, Inc. from 2020 to 2022.
Charlton earned a doctorate degree from the University of Southern California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
0.13% | 2024-03-24 | 55,373 ( 0.13% ) | 28 683 $ | 2024-06-29 |
Ralph Charlton active positions
| Companies | Position | Start |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-03-13 |
Former positions of Ralph Charlton
| Companies | Position | End |
|---|---|---|
| 89BIO, INC. | Chief Tech/Sci/R&D Officer | 2022-01-31 |
| Ascendis Pharma, Inc. | Chief Tech/Sci/R&D Officer | 2020-10-31 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 2019-04-30 |
Training of Ralph Charlton
| University of Southern California | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| 89BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Ascendis Pharma, Inc. | |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
- Stock Market
- Insiders
- Ralph Charlton
